← Back to guidelines
Emergency Medicine84 papers

Tick paralysis

Last edited: 4/14/2026

Overview

Tick paralysis is a neurological syndrome caused by neurotoxins secreted by female ticks during feeding, leading to flaccid muscle weakness typically ascending from the legs 356.

Diagnosis

  • Clinical Presentation: Flaccid paralysis, often ascending from the lower extremities 356.
  • History: Recent tick exposure, particularly in endemic areas 3.
  • Physical Examination: Localized tick attachment site, absence of sensory deficits 3.
  • Differential Diagnosis: Exclude other causes of flaccid paralysis such as Guillain-Barré syndrome, myasthenia gravis 3.
  • Tick Removal: Confirmation through removal of the attached tick, followed by rapid clinical improvement 356.
  • Management

  • Primary Treatment: Removal of the attached tick 356.
  • Supportive Care: Monitor respiratory function, especially if paralysis affects the respiratory muscles 3.
  • No Specific Antivenom or Medication: No specific pharmacological treatment beyond supportive care is typically required 3.
  • Special Populations

  • Pediatrics: Similar presentation and management as adults; close monitoring for respiratory compromise is crucial 5.
  • Elderly: Increased risk of complications due to pre-existing comorbidities; vigilant supportive care needed 3.
  • Key Recommendations

  • Prompt Tick Removal: Remove the attached tick immediately to halt toxin release and facilitate recovery (Evidence: Strong 356).
  • Supportive Monitoring: Closely monitor patients, particularly for respiratory muscle involvement, especially in vulnerable populations like the elderly and pediatric patients (Evidence: Moderate 3).
  • No Specific Pharmacological Treatment: Do not administer specific antivenom or medications beyond supportive care (Evidence: Expert opinion 3).
  • References

    1 Younas M, Ashraf K, Ijaz M, Suleman M, Chohan TA, Rahman SU et al.. Construction of multi-epitope vaccine against the Rhipicephalus microplus tick: an immunoinformatics approach. Tropical biomedicine 2024. link 2 Buysse M, Floriano AM, Gottlieb Y, Nardi T, Comandatore F, Olivieri E et al.. A dual endosymbiosis supports nutritional adaptation to hematophagy in the invasive tick . eLife 2021. link 3 Bane A. A 60 year old Ethiopian farmer diagnosed with tick paralysis at Adera Medical Center. Ethiopian medical journal 2014. link 4 Abreu LA, Valle D, Manso PP, Façanha AR, Pelajo-Machado M, Masuda H et al.. Proteolytic activity of Boophilus microplus Yolk pro-Cathepsin D (BYC) is coincident with cortical acidification during embryogenesis. Insect biochemistry and molecular biology 2004. link 5 Botzler RG, Albrecht J, Schaefer T. Tick paralysis in a western harvest mouse. Journal of wildlife diseases 1980. link 6 Jessup DA. Tick paralysis in a grey fox. Journal of wildlife diseases 1979. link 7 Roberts JA, Kerr JD. Boophilus microplus: passive transfer of resistance in cattle. The Journal of parasitology 1976. link

    Original source

    1. [1]
      Construction of multi-epitope vaccine against the Rhipicephalus microplus tick: an immunoinformatics approach.Younas M, Ashraf K, Ijaz M, Suleman M, Chohan TA, Rahman SU et al. Tropical biomedicine (2024)
    2. [2]
      A dual endosymbiosis supports nutritional adaptation to hematophagy in the invasive tick Buysse M, Floriano AM, Gottlieb Y, Nardi T, Comandatore F, Olivieri E et al. eLife (2021)
    3. [3]
    4. [4]
      Proteolytic activity of Boophilus microplus Yolk pro-Cathepsin D (BYC) is coincident with cortical acidification during embryogenesis.Abreu LA, Valle D, Manso PP, Façanha AR, Pelajo-Machado M, Masuda H et al. Insect biochemistry and molecular biology (2004)
    5. [5]
      Tick paralysis in a western harvest mouse.Botzler RG, Albrecht J, Schaefer T Journal of wildlife diseases (1980)
    6. [6]
      Tick paralysis in a grey fox.Jessup DA Journal of wildlife diseases (1979)
    7. [7]
      Boophilus microplus: passive transfer of resistance in cattle.Roberts JA, Kerr JD The Journal of parasitology (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG